The trial demonstrated significant benefits of MMAE adjunct with surgery at 6 months, a favorable trend with MMAE in nonsurgical management and a significant treatment effect for MMAE in patients aged ≥75 years undergoing surgery.
← all excerpts
Consensus Statement on Middle Meningeal Artery Embolization in Chronic Subdural Hematoma Treatment: A Guideline from the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee.
1
—
—